Related references
Note: Only part of the references are listed.BRD4 localization to lineage-specific enhancers is associated with a distinct transcription factor repertoire
Zeynab Najafova et al.
NUCLEIC ACIDS RESEARCH (2017)
Cadherin-6 promotes EMT and cancer metastasis by restraining autophagy
M. Gugnoni et al.
ONCOGENE (2017)
CBX4 Suppresses Metastasis via Recruitment of HDAC3 to the Runx2 Promoter in Colorectal Carcinoma
Xin Wang et al.
CANCER RESEARCH (2016)
The Ties That Bind: Mapping the Dynamic Enhancer-Promoter Interactome
Cailyn H. Spurrell et al.
CELL (2016)
Ever-Changing Landscapes: Transcriptional Enhancers in Development and Evolution
Hannah K. Long et al.
CELL (2016)
Nucleotide excision repair is impaired by binding of transcription factors to DNA
Radhakrishnan Sabarinathan et al.
NATURE (2016)
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer
Shaokun Shu et al.
NATURE (2016)
Hierarchy within the mammary STAT5-driven Wap super-enhancer
Ha Youn Shin et al.
NATURE GENETICS (2016)
Genetic dissection of the α-globin super-enhancer in vivo
Deborah Hay et al.
NATURE GENETICS (2016)
Histone Deacetylase Inhibitors Repress Tumoral Expression of the Proinvasive Factor RUNX2
Valentina Sancisi et al.
CANCER RESEARCH (2015)
Architectural and Functional Commonalities between Enhancers and Promoters
Tae-Kyung Kim et al.
CELL (2015)
BET Bromodomain Inhibition Suppresses the Function of Hematopoietic Transcription Factors in Acute Myeloid Leukemia
Jae-Seok Roe et al.
MOLECULAR CELL (2015)
Convergence of Developmental and Oncogenic Signaling Pathways at Transcriptional Super-Enhancers
Denes Hnisz et al.
MOLECULAR CELL (2015)
Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer
Zhong Chen et al.
NATURE COMMUNICATIONS (2015)
Induction of USP17 by combining BET and HDAC inhibitors in breast cancer cells
Gabor Borbely et al.
ONCOTARGET (2015)
Somatic Cell Fusions Reveal Extensive Heterogeneity in Basal-like Breast Cancer
Ying Su et al.
CELL REPORTS (2015)
STRING v10: protein-protein interaction networks, integrated over the tree of life
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2015)
Resistance to everolimus driven by epigenetic regulation of MYC in ER plus breast cancers
Teeru Bihani et al.
ONCOTARGET (2015)
The Mechanisms behind the Therapeutic Activity of BET Bromodomain Inhibition
Junwei Shi et al.
MOLECULAR CELL (2014)
BRD4 assists elongation of both coding and enhancer RNAs by interacting with acetylated histones
Tomohiko Kanno et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2014)
The bone-specific Runx2-P1 promoter displays conserved three-dimensional chromatin structure with the syntenic Supt3h promoter
A. Rasim Barutcu et al.
NUCLEIC ACIDS RESEARCH (2014)
BET and HDAC inhibitors induce similar genes and biological effects and synergize to kill in Myc-induced murine lymphoma
Joydeep Bhadury et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Genetic Screens in Human Cells Using the CRISPR-Cas9 System
Tim Wang et al.
SCIENCE (2014)
Opposing TNF-α/IL-1β- and BMP-2-activated MAPK signaling pathways converge on Runx2 to regulate BMP-2-induced osteoblastic differentiation
R-L Huang et al.
CELL DEATH & DISEASE (2014)
Bromodomain Protein BRD4 Is Required for Estrogen Receptor-Dependent Enhancer Activation and Gene Transcription
Sankari Nagarajan et al.
CELL REPORTS (2014)
Discovery and Characterization of Super-Enhancer-Associated Dependencies in Diffuse Large B Cell Lymphoma
Bjoern Chapuy et al.
CANCER CELL (2013)
Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes
Warren A. Whyte et al.
CELL (2013)
Super-Enhancers in the Control of Cell Identity and Disease
Denes Hnisz et al.
CELL (2013)
RUNX2 in mammary gland development and breast cancer
Nicola Ferrari et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
Estrogen Receptor α (ERα) and Estrogen Related Receptor α (ERRα) are both transcriptional regulators of the Runx2-I isoform
Martial Kammerer et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
Enhancers: five essential questions
Len A. Pennacchio et al.
NATURE REVIEWS GENETICS (2013)
HDAC inhibitors induce transcriptional repression of high copy number genes in breast cancer through elongation blockade
Y. J. Kim et al.
ONCOGENE (2013)
Cadherin 6 Is a New RUNX2 Target in TGF-β Signalling Pathway
Valentina Sancisi et al.
PLOS ONE (2013)
Multiplex Genome Engineering Using CRISPR/Cas Systems
Le Cong et al.
SCIENCE (2013)
Clinical significance of RUNX2 expression in patients with nonsmall cell lung cancer: a 5-year follow-up study
Hong Li et al.
TUMOR BIOLOGY (2013)
Extensive Promoter-Centered Chromatin Interactions Provide a Topological Basis for Transcription Regulation
Guoliang Li et al.
CELL (2012)
Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family
Panagis Filippakopoulos et al.
CELL (2012)
Runt-related transcription factor 2 in human colon carcinoma: A potent prognostic factor associated with estrogen receptor
Tomohiko Sase et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Runx2 Isoform I Controls a Panel of Proinvasive Genes Driving Aggressiveness of Papillary Thyroid Carcinomas
Valentina Sancisi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
An integrated encyclopedia of DNA elements in the human genome
Ian Dunham et al.
NATURE (2012)
Transcription factors: from enhancer binding to developmental control
Francois Spitz et al.
NATURE REVIEWS GENETICS (2012)
Analysis of long-range chromatin interactions using Chromosome Conformation Capture
Natalia Naumova et al.
METHODS (2012)
Complex interactions between cis-regulatory modules in native conformation are critical for Drosophila snail expression
Leslie Dunipace et al.
DEVELOPMENT (2011)
Ugonin K promotes osteoblastic differentiation and mineralization by activation of p38 MAPK- and ERK-mediated expression of Runx2 and osterix
Chia-Hsin Lee et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
HDAC Inhibition Decreases the Expression of EGFR in Colorectal Cancer Cells
Chia-Wei Chou et al.
PLOS ONE (2011)
Multiple enhancers ensure precision of gap gene-expression patterns in the Drosophila embryo
Michael W. Perry et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Shadow Enhancers Foster Robustness of Drosophila Gastrulation
Michael W. Perry et al.
CURRENT BIOLOGY (2010)
Runx2 Deficiency in Mice Causes Decreased Thyroglobulin Expression and Hypothyroidism
Toyoshi Endo et al.
MOLECULAR ENDOCRINOLOGY (2010)
Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions
J. Akech et al.
ONCOGENE (2010)
Ectopic Runx2 Expression in Mammary Epithelial Cells Disrupts Formation of Normal Acini Structure: Implications for Breast Cancer Progression
Jitesh Pratap et al.
CANCER RESEARCH (2009)
Pharmacologic suppression of MITF expression via HDAC inhibitors in the melanocyte lineage
Satoru Yokoyama et al.
PIGMENT CELL & MELANOMA RESEARCH (2008)
Advances in Runx2 regulation and its isoforms
Ya-lin Li et al.
MEDICAL HYPOTHESES (2007)
Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone
J. Pratap et al.
CANCER AND METASTASIS REVIEWS (2006)
The RUNX genes: Gain or loss of function in cancer
K Blyth et al.
NATURE REVIEWS CANCER (2005)
Share Paper
